MXPA03001027A - Vacunacion contra herpesvirus asociados a celulas huesped. - Google Patents
Vacunacion contra herpesvirus asociados a celulas huesped.Info
- Publication number
- MXPA03001027A MXPA03001027A MXPA03001027A MXPA03001027A MXPA03001027A MX PA03001027 A MXPA03001027 A MX PA03001027A MX PA03001027 A MXPA03001027 A MX PA03001027A MX PA03001027 A MXPA03001027 A MX PA03001027A MX PA03001027 A MXPA03001027 A MX PA03001027A
- Authority
- MX
- Mexico
- Prior art keywords
- host cell
- vaccination against
- herpesvirus
- herpesviruses
- against host
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion esta relacionada con el campo de los denominados herpesvirus asociados a la celula huesped, tales como un virus similar a la enfermedad de Marek (VDM) en aves de corral y el Virus de la Varicela Zoster (WZ) de seres humanos y a la vacunacion contra las enfermedades causadas por estos virus. La presente invencion proporciona una vacuna dirigida contra una infeccion causada por un herpesvirus que esta esencialmente asociado con la celula huesped, en donde la vacuna comprende un genoma viral recombinante derivado de dicho herpesvirus, en donde el genoma permite una recombinacion esencialmente sin la presencia de las celulas huesped.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00202757A EP1178111A1 (en) | 2000-08-03 | 2000-08-03 | Vaccination against host cell-associated herpesviruses |
PCT/EP2001/008893 WO2002012288A2 (en) | 2000-08-03 | 2001-08-01 | Vaccination against host cell-associated herpesviruses |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03001027A true MXPA03001027A (es) | 2004-02-26 |
Family
ID=8171884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03001027A MXPA03001027A (es) | 2000-08-03 | 2001-08-01 | Vacunacion contra herpesvirus asociados a celulas huesped. |
Country Status (24)
Country | Link |
---|---|
US (1) | US9073979B2 (es) |
EP (2) | EP1178111A1 (es) |
JP (1) | JP4313036B2 (es) |
KR (1) | KR100633180B1 (es) |
CN (2) | CN102151333A (es) |
AT (1) | ATE412055T1 (es) |
AU (2) | AU2001291716B2 (es) |
BR (1) | BRPI0112989B1 (es) |
CA (1) | CA2417923C (es) |
CZ (1) | CZ303904B6 (es) |
DE (1) | DE60136278D1 (es) |
EA (1) | EA010721B1 (es) |
ES (1) | ES2315306T3 (es) |
HR (1) | HRP20030147B1 (es) |
HU (1) | HU228262B1 (es) |
IL (2) | IL154250A0 (es) |
MX (1) | MXPA03001027A (es) |
NO (1) | NO332621B1 (es) |
NZ (1) | NZ524066A (es) |
PL (1) | PL207958B1 (es) |
PT (1) | PT1307565E (es) |
UA (1) | UA84667C2 (es) |
WO (1) | WO2002012288A2 (es) |
ZA (1) | ZA200300842B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
WO2005085445A1 (ja) * | 2004-03-05 | 2005-09-15 | The Research Foundation For Microbial Diseases Of Osaka University | 組換え水痘帯状疱疹ウイルス |
US9273326B2 (en) | 2004-04-30 | 2016-03-01 | The Brigham And Women's Hospital, Inc. | Tetracycline-regulated gene expression in HSV-1 vectors |
US20080226677A1 (en) * | 2004-05-06 | 2008-09-18 | Yasuko Mori | Recombinant virus vector for gene transfer into lymphoid cells |
EP3756684A1 (en) | 2009-05-22 | 2020-12-30 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
US8809047B2 (en) | 2009-12-21 | 2014-08-19 | The Brigham And Women's Hospital, Inc. | Herpes simplex virus vaccines |
US9782474B2 (en) * | 2010-11-24 | 2017-10-10 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
ES2700243T3 (es) * | 2011-10-21 | 2019-02-14 | Intervet Int Bv | Construcciones del virus de la enfermedad de Marek recombinantes no patógenas que codifican antígenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad de Newcastle |
EP2782597B1 (en) * | 2011-11-23 | 2022-04-13 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
CN105597095A (zh) * | 2015-12-30 | 2016-05-25 | 暨南大学 | 一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法 |
CN105561303B (zh) * | 2015-12-30 | 2019-04-05 | 暨南大学 | 单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法 |
CN105641692A (zh) * | 2015-12-30 | 2016-06-08 | 暨南大学 | 单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法 |
JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
US11174322B2 (en) * | 2017-07-24 | 2021-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies and peptides to treat HCMV related diseases |
BR112020012162A2 (pt) * | 2017-12-20 | 2020-11-24 | Intervet International B.V. | diluente aprimorado para vacina contra alfa-herpesvírus associado à célula |
WO2019152821A1 (en) | 2018-02-05 | 2019-08-08 | The Brigham And Women's Hospital, Inc. | Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959466A (en) * | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
GB8821441D0 (en) | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
EP0486106A3 (en) | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
JP3675569B2 (ja) | 1995-04-28 | 2005-07-27 | 日本ゼオン株式会社 | 組み換えウイルス及びそれよりなるワクチン |
KR19990028766A (ko) | 1995-07-07 | 1999-04-15 | 나카노 가쓰히꼬 | 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도 |
US6306387B1 (en) * | 1997-05-29 | 2001-10-23 | The Research Foundation Of State University Of New York | Antigen delivery system |
DE19733364A1 (de) * | 1997-08-01 | 1999-02-04 | Koszinowski Ulrich H Prof | Verfahren zur Klonierung eines großen Virusgenoms |
AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
EP1038952A3 (en) | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
US6410222B1 (en) * | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
-
2000
- 2000-08-03 EP EP00202757A patent/EP1178111A1/en not_active Withdrawn
-
2001
- 2001-01-08 UA UA2003021829A patent/UA84667C2/ru unknown
- 2001-08-01 JP JP2002518259A patent/JP4313036B2/ja not_active Expired - Lifetime
- 2001-08-01 EA EA200300215A patent/EA010721B1/ru not_active IP Right Cessation
- 2001-08-01 KR KR1020037001366A patent/KR100633180B1/ko active IP Right Grant
- 2001-08-01 CN CN2011100310998A patent/CN102151333A/zh active Pending
- 2001-08-01 WO PCT/EP2001/008893 patent/WO2002012288A2/en active IP Right Grant
- 2001-08-01 EP EP01971839A patent/EP1307565B1/en not_active Expired - Lifetime
- 2001-08-01 ES ES01971839T patent/ES2315306T3/es not_active Expired - Lifetime
- 2001-08-01 PL PL365190A patent/PL207958B1/pl unknown
- 2001-08-01 CN CNA018167950A patent/CN1503843A/zh active Pending
- 2001-08-01 AU AU2001291716A patent/AU2001291716B2/en not_active Ceased
- 2001-08-01 CA CA2417923A patent/CA2417923C/en not_active Expired - Lifetime
- 2001-08-01 BR BRPI0112989A patent/BRPI0112989B1/pt active IP Right Grant
- 2001-08-01 HU HU0302664A patent/HU228262B1/hu unknown
- 2001-08-01 NZ NZ524066A patent/NZ524066A/en not_active IP Right Cessation
- 2001-08-01 DE DE60136278T patent/DE60136278D1/de not_active Expired - Lifetime
- 2001-08-01 AU AU9171601A patent/AU9171601A/xx active Pending
- 2001-08-01 PT PT01971839T patent/PT1307565E/pt unknown
- 2001-08-01 MX MXPA03001027A patent/MXPA03001027A/es active IP Right Grant
- 2001-08-01 CZ CZ20030324A patent/CZ303904B6/cs not_active IP Right Cessation
- 2001-08-01 AT AT01971839T patent/ATE412055T1/de active
- 2001-08-01 IL IL15425001A patent/IL154250A0/xx unknown
-
2003
- 2003-01-30 ZA ZA200300842A patent/ZA200300842B/en unknown
- 2003-01-30 US US10/354,932 patent/US9073979B2/en active Active
- 2003-02-02 IL IL154250A patent/IL154250A/en not_active IP Right Cessation
- 2003-02-03 NO NO20030524A patent/NO332621B1/no not_active IP Right Cessation
- 2003-02-28 HR HR20030147A patent/HRP20030147B1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03001027A (es) | Vacunacion contra herpesvirus asociados a celulas huesped. | |
Li et al. | Molecular characterization of the genome of duck enteritis virus | |
Davison | Evolution of the herpesviruses | |
Mettenleiter | Molecular biology of pseudorabies (Aujeszky's disease) virus | |
Rowe et al. | Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity | |
EP1298139A3 (en) | Avian herpes virus-based recombinant infectious bursal disease vaccine | |
BR0014171A (pt) | Composição | |
UA84254C2 (ru) | МИНИМАЛЬНАЯ ПЛАЗМИДНАЯ СИСТЕМА ДЛЯ ГЕНЕРИРОВАНИЯ ИНФЕКЦИОННЫХ МИНУС-ЦЕПОЧЕЧНЫХ РНК ВИРУСОВ С КЛОНИРОВАННОЙ ВИРУСНОЙ кДНК, КЛЕТКА-ХОЗЯИН, КОТОРАЯ ВКЛЮЧАЕТ ПЛАЗМИДНУЮ СИСТЕМУ, СПОСОБ ПРОДУЦИРОВАНИЯ ИНФЕКЦИОННОГО МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА И СПОСОБ ПРИВИВКИ СУБЪЕКТА ОТ ИНФЕКЦИИ МИНУС-ЦЕПОЧЕЧНОГО РНК ВИРУСА | |
Rajčáni et al. | The potential of currently unavailable herpes virus vaccines | |
AU2002337083A1 (en) | Vaccinia virus mva-e3l-knockout-mutants and use thereof | |
Wu et al. | Prospects of a novel vaccination strategy for human gamma-herpesviruses | |
Lomonte et al. | Bovine herpesvirus 4: genomic organization and relationship with two other gammaherpesviruses, Epstein-Barr virus and herpesvirus saimiri | |
He et al. | Genomic analysis of a Chinese MDV strain derived from vaccine strain CVI988 through recombination | |
Pavlova et al. | Identification and functional analysis of membrane proteins gD, gE, gI, and pUS9 of Infectious laryngotracheitis virus | |
Cleator et al. | The herpesviridae | |
Nagesha et al. | Analysis of the nucleotide sequence of five genes at the left end of the unique short region of the equine herpesvirus 4 genome | |
Ohsawa et al. | Sequence and genetic arrangement of the UL region of the monkey B virus (Cercopithecine herpesvirus 1) genome and comparison with the UL region of other primate herpesviruses | |
DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
ATE317439T1 (de) | Virale vakzine | |
Li et al. | Comparative analysis of the genes UL1 through UL7 of the duck enteritis virus and other herpesviruses of the subfamily Alphaherpesvirinae | |
Stewart | Of mice and men: murine gammaherpesvirus 68 as a model | |
Aricò et al. | MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68 | |
Johnson et al. | Nucleotide sequence of the left-terminus of infectious laryngotracheitis virus (Gallid herpesvirus 1) SA-2 strain | |
HUP0002374A2 (hu) | Egy diszfunkcionális 71 gén régiót tartalmazó rekombináns 1-es típusú ló herpeszvírus (EHV-1) és alkalmazása vakcinaként | |
Becker | Live Herpesvirus Vaccines: Serendipity or Engineering of the Virus Genome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |